Jagsonpal's Q2 operating margin trails healthcare peer median
The consolidated quarter included Rs 2.02 cr of other income, while the results were filed after market close with no market reaction yet.
Filed 28 Oct 2026, 18:13 IST · after market close · Jagsonpal Pharmaceuticals Ltd (JAGSNPHARM)
Key takeaways
- Jagsonpal's consolidated operating margin was 17.54%, 2.36 percentage points below the 19.9% median for 23 healthcare peers.
- Net profit was Rs 12.29 cr, with Rs 2.02 cr of other income contributing alongside operating profit of Rs 16.90 cr.
- EPS was Rs 1.86 at a 25.17% tax rate, with the results filed after market close on 28 Oct 2026.
Price around the results
Core profit was the clearer read in Q2FY27
Jagsonpal reported consolidated operating profit of Rs 16.90 cr and net profit of Rs 12.29 cr. Other income of Rs 2.02 cr was also part of the quarter, making operating profit the cleaner measure of the business's reported earnings. The 25.17% tax rate resulted in EPS of Rs 1.86.
Operating margin sat below the healthcare peer median
Jagsonpal's 17.54% operating margin was 2.36 percentage points below the 19.9% median among 23 healthcare companies that had reported the same quarter. It ranked eighth from the bottom on this measure, placing its margin below the sector comparison set.
Results were filed after market close
The consolidated results were filed at 18:13 IST on 28 Oct 2026, after the market closed. There is no reported stock reaction yet, so the immediate market response cannot be assessed.
Q2FY27 at a glance
Consolidated figures as filed with NSE — filed ahead of third-party databases, not yet independently cross-checked.
| Line item | Q2FY27 |
|---|---|
| Revenue | ₹96 cr |
| Other income | ₹2 cr |
| Expenses | ₹79 cr |
| Operating profit | ₹17 cr |
| Operating margin (%) | 17.54% |
| Interest | ₹0 cr |
| Depreciation | ₹2 cr |
| Profit before tax | ₹16 cr |
| Tax | ₹4 cr |
| Net profit | ₹12 cr |
| EPS (₹) | ₹1.86 |
Operating margin of 17.54% compares with a Healthcare sector median of 19.90% across 23 peers that have reported Q2FY27.
What to watch
- Whether operating margin moves above 17.54% in the next reported quarter.
- Whether the 2.36-percentage-point gap to the healthcare peer median of 19.9% narrows.
- Whether other income remains at Rs 2.02 cr or becomes a larger part of reported profit.